DIRECTORATE GENERAL PHARMACEUTICAL DEVELOPMENT AND MEDICAL SERVICES
|
|
|
- Cory Mills
- 5 years ago
- Views:
Transcription
1 DIRECTORATE GENERAL PHARMACEUTICAL DEVELOPMENT AND MEDICAL SERVICES
2 OUTLINE I. Introduction II. Regulation III.Strategies to Improve Medicines Accessibility IV. Conclusion
3 I. INTRODUCTION
4 NATIONAL HEALTH SYSTEM a. To achieve the availability, fair distribution and affordability of medicines b. To ensure the safety, efficacy and quality of medicines and public protection c. To improve pharmaceutical care services d. To improve Rational Use of Medicine e. Selft reliance on medicines Medicines, Medical Devices and Food Human Resources Health Services National Health System Community Empowerment Health Financing Human Resources OBJECTIVE : Helath Development Good
5 II. REGULATION
6 HEALTH DEVELOPMENT IMPROVEMENT THE HEALTH DEGREE AND WELFARE To improve people access to health services, including safe, effective and good quality of medicines NATIONAL MEDICINES POLICY (Government Regulation number 7 of 2005 ) 6
7 AVAILABILITY, FAIR DISTRIBUTION AND AFFORDABILITY SAFETY, EFFICACY AND QUALITY NATIONAL MEDICINES POLICY Decree of Ministry of Health-Republic of Indonesia number 189/MENKES/SK/III/2006 RATIONAL USE OF MEDICINES PULIC PROTECTION 7
8 AVAILABILITY, FAIR DISTRIBUTION AND AFFORDABILITY 1. Production capacit of essensial medicine 2. The chain of distribution available from the central, provincial to local, public and private 3. Pharmacies should meet the standard of pharmaceutical services 4. Continuity of Budget (insurance) 5. Rational use of medicines
9 SAFETY, EFFICACY AND QUALITY 1. Good quality of raw material and doses form 2. Good Manufacturing Practice 3. Good Distribution Practice 4. Registered medicines use only 5. Labeling and package insert 6. Preventing illegal medicines
10 RATIONAL USE OF MEDICINES Diagnose Patient condition Indication Affordable Information RIGHT Medicines Aware of Adverse Drug Reaction Patients Need Dose, administration & duration
11 III. STRATEGIES TO IMPROVE MEDICINES ACCESSIBILITY 11
12 ACCESS TO ESSENTIAL MEDICINE I. Rational Use of Drug II. Affordability III. Financial Sustainablility IV. Health Care System V. Drug Supply System
13 STRATEGIES IN IMPROVING ACCESS TO MEDICINES : 1. Social inssurance 2. JAMKESMAS Formulary 3. Revitalize Reposition Generic Medicines 4. SAS (Special Access Scheme) for medicines that have not been registered in Indonesian 5. Orphan Drug in future IMPROVING ACCESS AFFORDABILITY 13
14 STRATEGIES IN IMPROVING MEDICINES ACCESSIBILITY.. (1) CONDITION (2010) Antineoplastic in Indonesia FORWARD Encourage local pharmaceutical companies to: 69 items 351 dosage forms Produce Import GOAL GENERIC IMPORTED 68 item LOCAL 1 item IMPROVING ACCESS 14
15 JAMKESMAS FORMULARY. (2) JAMKESMAS FORMULARY *Decree of Ministry of Health RI number : 1455/Menkes/SK/X/2010, 4 Oct 2010 List of Essential Medicines and the Information The corridor to health care giver to improve the health services for the member of Jamkesmas based on standard and criteria In hospital and other health care services as the guideline to program JAMKESMAS implementation 15
16 A. Common Use medicine Antineoplastic, Imunosupresan and Paliative therapy 8.3 Sitotoxid Asparaginase Bleomisin Busulfan Dakarbazin Doksorubisin Etoposid Fluorourasil Ifosfamid Kalsium folinat (leukovorin, ca) Karboplatin Klorambusil Melfalan Merkaptopurin Metotreksat Paklitaksel Prokarbazin Siklofosfamid Sisplatin Sitarabin Vinblastin Vinkristin medicine with 10 influence blood 10.3 Intoksikasi Zat Besi FORMULARY.. HEMATOLOGY- ONCOLOGY MEDICAL in JAMKESMAS FORMULARY B. Restricted Use Medicine 4 Antidot dan Other Medicines for Toxicity Deferasiroks Deferipron Kalsium folinat (leukovorin, Ca) Antineoplastic, Imunosupresan and Paliative 8 therapy 8.3 Sitotoksik 9 Dinatrium Klodronat 10 Irinotecan 11 Uromiteksan
17 REVITALIZE GENERIC MEDICINES.. (3) 1. Generic Medicines Pricing 2. Fast-track registration 3. Competitive and Conducive business climate Upstream Sector Downstream Sector Social Dimension Economy dimension Science and Technology MUTIDIMENSION IN MEDICINES USE 1. Obligation on generic prescribing in public health care 2. Generic substitution 3. Generic medicines in JAMKESMAS 4. Advocacy to stake holder and community 17
18 REPOSITION GENERIC MEDICINES (4) Grand Strategy Generic Medicines : Low price Grand Strategy Generic Medicines = Good Quality Community interpretation : Generic medicines = Medicines with low quality REPOSITION Generic has a good price and quality Doctors and patient will not have any doubt in generic use 18
19 LIMITED NON REGISTERED MEDICINES SPECIAL ACCESS SCHEME / SAS (5) MEDICINES (incl. product biology) Medical Devices cytotoxic IMPORT DONATION SAS AKSES Disaster/epidemic/ outbreak Program needs Health care (hospital, primary health care, research center) PATIENT/COMMUNITY Processed Food (for therapy) Essential for health care NON DONATION Program needs Health care (hospital, primary health care, research center Institution/ Private procurement 19
20 IV. CONCLUSION Medicines accessibility has an important role in achieving goal of therapy. Government strategies in improving medicines accessibility : Social insurance Jamkesmas formulary Revitalize and Reposition of Generic Medicines Orphan drugs 20
21 Thank you
NATIONAL DRUG POLICY OF THE TRANSITIONAL GOVERNMENT OF ETHIOPIA
NATIONAL DRUG POLICY OF THE TRANSITIONAL GOVERNMENT OF ETHIOPIA Nov. 1993 NATIONAL DRUG POLICY OF THE TRANSITIONAL GOVERNMENT OF ETHIOPIA 5. Introduction Based on economic development
Designing publicly funded healthcare markets Note by the Russian Federation
Organisation for Economic Co-operation and Development DAF/COMP/WP2/WD(2018)42 DIRECTORATE FOR FINANCIAL AND ENTERPRISE AFFAIRS COMPETITION COMMITTEE English - Or. English 5 November 2018 Working Party
Report. Uganda Pharmaceutical Sector Scan JUNE 2010
Report On the Uganda Pharmaceutical Sector Scan Part of Component 1 of MeTA Baseline Assessments JUNE 2010 Drafted by consultants: 1. Samuel Balyejjusa, B.Pharm., MPH 2. Paschal Mujasi, B.Pharm., MBA 3.
INDONESIA HEALTH CARE SECTOR CHANGE OF PARADIGM
INDONESIA HEALTH CARE SECTOR CHANGE OF PARADIGM Chrisma A. Albandjar Special Advisor to the Chief of Staff Executive Office of the President. 8 November 2016 EU Indonesia Business Dialogue Realization
CHAPTER-I. Concept of essential drugs. BY: J. jayasutha lecturer department of pharmacy practice Srm college of pharmacy SRM UNIVERSITY
CHAPTER-I Concept of essential drugs BY: J. jayasutha lecturer department of pharmacy practice Srm college of pharmacy SRM UNIVERSITY Definition Essential drugs are those that satisfy the health care needs
The pathway to better medicines for children
The pathway to better medicines for children As the World Health Organization counts down to 2015 and the Millennium Development Goal to reduce under five-year-old mortality by two-thirds, we reflect on
Guideline for the Rational Use of Controlled Drugs
Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import
Pharmaceutical Pricing & Reimbursement Information. PPRI Project Co-ordination Sabine Vogler, Gesundheit Österreich GmbH
PPRI - Comparative Analysis PPRI Project Co-ordination Sabine Vogler, Gesundheit Österreich GmbH PPRI Conference Vienna, 29 June 2007 PPRI Conference, Vienna, 29 June 2007 1 Comparative Analysis - Outline
Essential Medicines List
Essential Medicines List Mohan P. Joshi, MBBS, MSc, MD Principal Technical Advisor for Pharmaceutical Services, SIAPS West Virginia University Global Health Program Annual Summer Tropical Medicine Course
MEDICINES PROMOTION AND RATIONAL USE : The Spanish Experience JOSE LUIS DOPICO
MEDICINES PROMOTION AND RATIONAL USE : The Spanish Experience JOSE LUIS DOPICO LEGAL FRAMEWORK General Health Act (1986): Established a National Health System in Spain in accordance with the following
Heng-Jung Lien 衛生福利部食品藥物管理署. Section Chief. Food and Drug Administration, Ministry of Health and Welfare
Heng-Jung Lien Section Chief Division of Medicinal Products, Food and Drug Administration, Ministry of Health and Welfare, Taiwan, R.O.C. 衛生福利部食品藥物管理署 Food and Drug Administration, Ministry of Health and
LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY
LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY President s Office No. 13/PO DECREE of the PRESIDENT of the LAO PEOPLE S DEMOCRATIC REPUBLIC On the Promulgation of the Law
Essential Medicines for Universal Health Coverage. Highlights of the report
Essential Medicines for Universal Health Coverage Highlights of the report Scope and process Prompted by the 30 th anniversary of the 1985 Nairobi Conference on the Rational Use of Drugs, to ask: 1. What
NATIONAL OPEN UNIVERSITY OF NIGERIA
NATIONAL OPEN UNIVERSITY OF NIGERIA SCHOOL OF HEALTH SCIENCES COURSE CODE: PHS 426 COURSE TITLE: Essential Drug Supply Systems COURSE GUIDE COURSE CODE: PHS 426 COURSE TITLE: ESSENTIAL DRUG SUPPLY SYSTEMS
Position Paper on Good & Services Tax (GST) on Medicines Why All Medicines Should Be Accorded GST Zero- Rate Treatment in Malaysia
Position Paper on Good & Services Tax (GST) on Medicines Why All Medicines Should Be Accorded GST Zero- Rate Treatment in Malaysia INTRODUCTION: Medicines are essential and critical goods for all Malaysian
REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD
REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD Ensuring the provision of quality, safe and efficacious pharmaceutical products and services. FUNCTIONS OF THE BOARD BACKGROUND
Access to Vaccines: Where are we, Why are we there, Where do we need to get to? Martin Friede Initiative for Vaccine Research
Access to Vaccines: Where are we, Why are we there, Where do we need to get to? Martin Friede Initiative for Vaccine Research Vaccines work, but vaccine preventable diseases are still a significant cause
Legal Framework: Counterfeit Medicines.
Legal Framework: Counterfeit Medicines. AIFA and the actions against drugs counterfeiting Marcello Chiavoni Zagreb, November 2014 Public Declaration of transparency/interests* The view and opinions expressed
The South African Depression and Anxiety Group (SADAG) Competition Commission: Market Inquiry into the Private Healthcare Sector
The South African Depression and Anxiety Group (SADAG) Competition Commission: Market Inquiry into the Private Healthcare Sector Introduction SADAG is registered NGO since 1994 Leading Mental Health Advocacy
Pharmaceutical Sector Scan
Pharmaceutical Sector Scan Part of Component 1 of MeTA Baseline Assessments Part II - Data Forms Country: ZAMBIA Data Collected By: ANGELA TAYLOR Bsc Pharm; CHIDADZA DAKA Dip Pharm; KAMBUZA RUWE Dip Pharm;
DECISION OF THE DIRECTOR GENERAL OF CUSTOMS AND EXCISE NO. KEP-22/BC/2001 DATED APRIL 20, 2001 PACKAGES OF RETAILED TOBACCO PRODUCTS
DECISION OF THE DIRECTOR GENERAL OF CUSTOMS AND EXCISE NO. KEP-22/BC/2001 DATED APRIL 20, 2001 PACKAGES OF RETAILED TOBACCO PRODUCTS THE DIRECTOR GENERAL OF CUSTOMS AND EXCISE, Considering : that in the
Essential Medicines. WHO
12 Health Technology and Pharmaceuticals Participants to the Workshop on Pharmaceutical Policies and Access to Good Quality Essential Medicines for Pacific Island Countries observing pharmaceutical services
RESOLUTION OF THE STATE GREAT KHURAL OF MONGOLIA. 11 October 2002 No: 68 Ulaanbaatar. Adoption of the Government Policy on Drugs
Translation from Mongolian RESOLUTION OF THE STATE GREAT KHURAL OF MONGOLIA 11 October 2002 No: 68 Ulaanbaatar Adoption of the Government Policy on Drugs The State Great Khural of Mongolia RESOLVES: 1.
MDR-TB: Medicine quality and rational use
MDR-TB: Medicine quality and rational use Hans V. Hogerzeil, MD, PhD, FRCP Edin Director, Essential Medicines and Pharmaceutical Policies WHO, Geneva 1 Can we rely on essential medicines against TB? (1)
Establishment of a New Drug Code for Marihuana Extract. AGENCY: Drug Enforcement Administration, Department of Justice.
This document is scheduled to be published in the Federal Register on 12/14/2016 and available online at https://federalregister.gov/d/2016-29941, and on FDsys.gov Billing Code 4410-09-P DEPARTMENT OF
Unofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control
Unofficial translation /Ministry of Social Affairs and Health No. 548/2008 Government Decree on Narcotics Control Issued in Helsinki on 28 August 2008 Section 1 Scope of application This Decree lays down
10 th Annual African Vaccinology Course (AAVC) Cape Town 10 November 2014
Operational Challenges of Vaccination Programmes in Africa 10 th Annual African Vaccinology Course (AAVC) Cape Town 10 November 2014 Johann van den Heever: NDoH EPI Manager Outline Challenges of a Vaccination
MeTA Jordan Case Study on CSOs in Jordan
MeTA Jordan Case Study on CSOs in Jordan Title: Jordan moves forward in CSOs building capacity through training on advocacy and communication to engage them in the process of improving access to essential
Harnessing the Cooperative Advantage to Build a Better World, Global Forum on Cooperatives, UNDESA, Addis Ababa, 4 6 September 2012,
Harnessing the Cooperative Advantage to Build a Better World, Global Forum on Cooperatives, UNDESA, Addis Ababa, 4 6 September 2012, UN African Union Social Development Policies: Implementation Challenges
Location of HENGRUI. The Headquarters: No.7 Kunlunshan Road, Economic & Technological Development Zone Lianyungang, Jiangsu, China
1 Location of HENGRUI The Headquarters: No.7 Kunlunshan Road, Economic & Technological Development Zone Lianyungang, Jiangsu, China 2 Domestic Achievements No. 1 in Market Cap No. 1 in Innovation No. 1
AGRICULTURE SECTOR GENDER HIV AND AIDS STRATEGY
MALAWI GOVERNMENT AGRICULTURE SECTOR GENDER HIV AND AIDS STRATEGY ABRIDGED VERSION Ministry of Agriculture, Irrigation and Water Development Designedand printed by Agricultural Communication Branch Department
Sustainability Report
2017 Sustainability Report We have a great future that we are building today for the next generation of pharmacists. Professionalism, innovation and sustainability are the principles on which we base this
SADAG submission to the Competition Commission: Market Inquiry into the Private Healthcare Sector
THE SOUTH AFRICAN DEPRESSION AND ANXIETY GROUP NPO 013-085 Reg. No. 2000/025903/08 P O Box 652548 Benmore 2010 Tel: +27 11 234 4870 Fax: +27 11 234 8182 office@anxiety.org.za www.sadag.org SADAG submission
Tunisia. Medicine prices, availability, affordability and price components. Medicine prices matter. Tunisia
prices, availability, affordability and price components prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially in developing and transitional
Beyond vaccine introduction: Working together for sustainable, resilient immunization programs Manufacturer perspective
Beyond vaccine introduction: Working together for sustainable, resilient immunization programs Manufacturer perspective IAIM Regional Meeting for the Americas and Europe 1 February 2017 Anupama Tantri
Fifth report of Committee A
SIXTY-EIGHTH WORLD HEALTH ASSEMBLY (Draft) A68/73 26 May 2015 Fifth report of Committee A (Draft) Committee A held its twelfth and thirteenth meetings on 25 May 2015 under the chairmanship of Dr Eduardo
The Danish Medicines Agency s availability strategy
låst DECEMBER 2016 The Danish Medicines Agency s availability strategy 2017 2021 Danish Medicines Agency, 2016 This publication may be freely quoted with appropriate acknowledgement of the source. Images
Framework for Changing Drug Use Practices
Framework for Changing Drug Use Practices 1 Framework for Changing Drug Use Practices: Objectives Identify specific drug use problems and place in perspective of underlying causes Identify 8-10 educational,
Tamsulosin Hydrochloride 0.4 mg Capsule
Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule
Shanghai. China. Medicine prices, availability and affordability
Shanghai China Medicine prices, availability and affordability Medicine prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially in developing
World Organisation for Animal Health
World Organisation for Animal Health Dr Bernard Vallat Director General Good Governance Programme, Achievements, Needs and Gaps 4 th International Conference on Avian Influenza; Bamako, Mali 6-8 December
Adult Intravenous Systemic Anticancer Therapy (SACT) Section A. SUMMARY of SCHEME QIPP Reference
CA2 Nationally standardised Dose banding for Adult Intravenous Anticancer Therapy (SACT) Scheme Name CA2: Nationally Standardised Dose Banding for Adult Intravenous Systemic Anticancer Therapy (SACT) Section
Immunization Financing Outlook: A Historical Perspective
Immunization Financing Outlook: A Historical Perspective Being a paper presented at the NIFT one day workshop held on 13 th Feb 2017 at Top Galaxy Hotel Kaduna By Ganiyu Salau Brief History of Immunization
Hepatitis and HIV Co-Infection: Situation in Ukraine.
2nd Central and Eastern European Meeting on Viral Hepatitis and Co-Infection with HIV Hepatitis and HIV Co-Infection: Situation in Ukraine. Pavlo Skala Associate Director: Policy & Partnership Ukraine
CONSOLIDATED RESULTS REPORT
CONSOLIDATED RESULTS REPORT Country: PERU Programme Cycle: 2006 to 2011 1. Key Results Expected 3. Key Progress Indicators (state the indicator, baseline and most recent status) 4. Description of Results
Access to Medicines in the Context of the Right to Health
Access to Medicines in the Context of the Right to Health An overview and WHO Perspective Human Rights Council SOCIAL FORUM 18 February 2015 Room XII, Palais des Nations, Geneva Zafar Mirza Public Health,
IDA and the concept of essential drugs
International Journal of Risk & Safety in Medicine 12 (1999) 75 77 75 IOS Press IDA and the concept of essential drugs Hans V. Hogerzeil Medical Officer, WHO Department of Essential Drugs and Other Medicines,
Micro Finance and Gender Equity in Indonesia
2011/GFPN/WKSP/024 Session 7 Micro Finance and Gender Equity in Indonesia Submitted by: Indonesia Workshop on Microfinance Best Practices Ha Noi, Viet Nam 7-8 April 2011 MINISTRY OF WOMEN EMPOWERMENT AND
NAMIBIA INVESTMENT CASE
NAMIBIA INVESTMENT CASE OUTLINE Why an Investment Case for HIV Response in Namibia? Investment Scenarios Can we achieve Fast Track and End AIDS as public health threat by 2030? Can we afford it? Efficiencies:
About the PCTB Examination Assisting the Pharmacist in Serving Patients p. 1 Filling the Medication Order p. 3 Receiving the Medication Order p.
Preface p. ix About the PCTB Examination p. xii Assisting the Pharmacist in Serving Patients p. 1 Filling the Medication Order p. 3 Receiving the Medication Order p. 4 The Retail Medication Order p. 6
Prof. Arnon Baruch Afek Director General of the Ministry of Health of the State of Israel
Prof. Arnon Baruch Afek Director General of the Ministry of Health of the State of Israel WHO and FAO 19-21 November Thank you, Mr. / Ms. Chair. I am grateful and honored to have the opportunity to address
A Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP)
A Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP) May 2014 RubiReview Program Overview... 3 Overview... 3 Adherence Packaging (RubiPaks)... 4 Eligibility... 4 Financial
Gavi s Sustainability and Transition Approach
Gavi s Sustainability and Transition Approach Santiago Cornejo Director, Immunisation Financing and Sustainability 13 June 2018 www.gavi.org Countries tend to face various programmatic and financing challenges
Nutraceuticals Regulatory Purview. - Dr. R. B. Smarta
Nutraceuticals Regulatory Purview - Dr. R. B. Smarta Nutraceuticals and Functional foods are the products whose safety for human consumption is very essential, since these products are directly consumed
DECREE. President of Islamic Republic of Afghanistan Regarding the enforcement of Medicine Law
Number: (116) Date: 18 th November 2008 Article 1: DECREE Of President of Islamic Republic of Afghanistan Regarding the enforcement of Medicine Law I, hereby, enforce the Law on Medicine which is approved
WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES
WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES Immunization and vaccine development in the last decade Since the Millennium Summit in 2000, immunization substantial international
PPFP Global Meeting Follow-up Workshop. Country Posters
PPFP Global Meeting Follow-up Workshop Country Posters Afghanistan Trained 12 family planning trainers in PPFP/PPIUD and developed plans to train 115 health care providers from 23 provinces in 4 regions
Indonesia. Stakeholder Report on Indonesia - Submission by World Vision Indonesia For Universal Periodic Review, 13 th session, 2012
Indonesia Stakeholder Report on Indonesia - Submission by World Vision Indonesia For Universal Periodic Review, 13 th session, 2012 Child and Maternal Health and Nutrition A) Scope of International Obligations
Keynote Address. at The Second International Conference on Improving Use of Medicines
Keynote Address by Dr Samlee Plianbangchang Regional Director, WHO/SEARO at The Second International Conference on Improving Use of Medicines Chiang Mai, Thailand 30 March -2 April 2004 Keynote Address
Highlights from the SUN Civil Society Network Annual Survey 2017 Img.1 SUNCSN Learning Route in Rwanda, Gisagara District
Highlights from the SUN Civil Society Network Annual Survey 2017 Img.1 SUNCSN Learning Route in Rwanda, Gisagara District The greatest, undeniable advantage of being part of the civil society alliance
Introduction on the Regulations on Imported Nutrition Supplements of the Republic of China
Introduction on the Regulations on Imported Nutrition Supplements of the Republic of China Preface With the aging of population in Taiwanese society, the people of Taiwan have become more health-conscious
Financing for Family Planning: Options and Challenges
Repositioning Family Planning and Reproductive Health in the region. Financing for Family Planning: Options and Challenges BASINGA Paulin, MD,MSc, PhD Senior Lecturer School of Public Health National University
Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services
United Nations Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services Distr.: General 29 September 2011 Original:
Office of the Auditor General Portage Avenue Winnipeg, Manitoba R3C 0C4
Office of the Auditor General 500-330 Portage Avenue Winnipeg, Manitoba R3C 0C4 April 2006 The Honourable George Hickes Speaker of the House Room 244, Legislative Building Winnipeg, Manitoba R3C 0V8 Dear
Presentation On the Gender Equality and Gender Machinery in Laos PDR
Presentation On the Gender Equality and Gender Machinery in Laos PDR By: Lavan SOUTHISAN 1 On the Gender Equality and Gender Machinery in Laos PDR 1. Gender situation in Lao PDR Women and education Women
MINISTRY OF PUBLIC HEALTH
MINISTRY OF THE INTERIOR MINISTRY OF FOREIGN AFFAIRS MINISTRY OF THE ECONOMY AND FINANCE MINISTRY OF NATIONAL DEFENSE MINISTRY OF EDUCATION AND CULTURE MINISTRY OF TRANSPORTATION AND PUBLIC WORKS MINISTRY
Ethical Practice Guidelines on Financial Incentives from Hearing Instrument Manufacturers
Ethical Practice Guidelines on Financial Incentives from Hearing Instrument Manufacturers Ethical Guidelines The following general guidelines have been accepted by the Board of Directors of the Academy
Kyrgyzstan. Medicine prices, availability, affordability & price components
Kyrgyzstan Medicine prices, availability, affordability & price components Medicine prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially
Authorization and appeals kit: Psoriatic arthritis
1 Authorization and appeals kit: Psoriatic arthritis Resources for healthcare providers INDICATIONS COSENTYX is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who
Understanding Your Patient Care Opportunity Report (PCOR)
Understanding Your Patient Care Opportunity Report (PCOR) Use your January/February 208 PCOR to help improve performance on Medicare Part D Clinical Star Ratings measures. Your January/February 208 Patient
14 th International Conference of Drug Regulatory Authorities : Progress report from the Western Pacific Region
14 th International Conference of Drug Regulatory Authorities : Progress report from the Western Pacific Region Budiono Santoso Team Leader Essential Medicines & Technologies, World Health Organization,
Ref.no 2712/ /2010. Guideline of the National Agency for Medicines 1/2005
Guideline 2/2010 1 (5) 9.12.2010 Ref.no 2712/03.01.01/2010 Reporting of adverse drug reactions Unofficial translation Target groups Persons authorised to prescribe or supply drugs Period of validity The
1. Project Description. by using the MCH HB at Posyandu)
Republic of Indonesia Ex-Post Evaluation of Japanese Technical Cooperation Project Project for Ensuring Maternal and Child Health Service with MCH HB Phase II External Evaluator: Hisae Takahashi, Ernst
Kuwait. Medicine prices, availability, affordability and price components. Medicine prices matter
prices, availability, affordability and price components prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially in developing and transitional
Government Agency Perspective on Future Access
Government Agency Perspective on Future Access UICC 4th December 2014 M. Saeed Quraishy Medical Superintendent & Chair Private Public Partnership Civil Hospital Karachi P A K I S T A N Cancer kills more
NATIONAL ACADEMY ON GREEN ECONOMY SOUTH AFRICA
NATIONAL ACADEMY ON GREEN ECONOMY SOUTH AFRICA ENHANCING CAPACITIES FOR TRANSFORMATIVE ACTION AT PROVINCIAL LEVEL Hlengiwe Radebe Sustainable Energy Africa Challenges and opportunities for gender equity
Public views invited in HA Drug Formulary Review
PRESS RELEASE 新聞稿 Hospital Authority Building, 147B, Argyle Street, Kowloon, Hong Kong Friday, 12 May 2006 Public views invited in HA Drug Formulary Review The Hospital Authority (HA) started the phases
Community Pharmacy Practice in Norway
Community Pharmacy Practice in Norway Contributed by: Cand.pharm. Rønnaug Larsen, President, The Norwegian Association of Pharmacists Norwegian facts - Kingdom with parliamentary democracy. - Population
Media Contacts: Kelley Dougherty Investor Contact: Graeme Bell (215) (908)
News Release Media Contacts: Kelley Dougherty Investor Contact: Graeme Bell (215) 652-0059 (908) 423-5185 Janet Skidmore (267) 305-7715 Merck Launches National Advertising Campaign for GARDASIL, Merck's
THE SOUTH AFRICAN CAMS & DIETARY SUPPLEMENTS CLIMATE 2016
Health Products Association (HPA) of South Africa THE SOUTH AFRICAN CAMS & DIETARY SUPPLEMENTS CLIMATE 2016 presented by Bruce Dennison President of HPASA SOUTH AFRICAN MARKET Annual GDP growth South Africa
Presentation to Parliamentary Portfolio Committee on Health
Presentation to Parliamentary Portfolio Committee on Health Bill 6 of 2014 Medicines and Related Substances Amendment Bill Presented by: Anele Vutha South African Medical Device Industry Association 29
Tobacco Control Efforts in Organization of Islamic Cooperation (OIC) Member Countries
Tobacco Control Efforts in Organization of Islamic Cooperation (OIC) Member Countries 6th National Conference on Tobacco or Health June 20,2012 Erzurum, Turkey Outline Tobacco Control Policies up to now
What is this document and who is it for?
Measles and Rubella Initiative s Standard Operating Procedures for Accessing Support for Measles and Rubella Supplementary Immunization Activities During 2016 In the context of measles and rubella elimination
Enhancing access to menstrual care products
Enhancing access to menstrual care products Preliminary findings from the rapid total market landscaping of menstrual care products in Kenya Nancy Muller Program Officer PATH Menstrual health landscape:
Health Technology Assessment and the Demands of the Fourth Hurdle Experiences from TLV in Sweden
1 Health Technology Assessment and the Demands of the Fourth Hurdle Experiences from TLV in Sweden Ulf Persson IHE, The Swedish Institute for Health Economics & Institute of Economic Research, School of
Ex post evaluation Indonesia
Ex post evaluation Indonesia Sector: 12230 Basic health infrastructure Programme/Project: CP Health sectoral programme (BMZ No. 2003 66 401)* Implementing agency: Ministry of Health Ex post evaluation
FINAL MAY 2017 Novo Nordisk Scandinavia AB Methodology Note - reporting year 2016 ( Methodology ) Preamble General Summary...
Novo Nordisk Scandinavia AB Methodology Note - reporting year 2016 ( Methodology ) Table of contents Preamble... 1 1. General Summary... 2 2. and Definitions... 3 Preamble Novo Nordisk Scandinavia AB (Novo
Breast Cancer. allied. Theme: Explore New Discoveries in Breast Cancer: Health Promotion and Awareness. 7 th World Congress on
7 th World Congress on allied academies Breast Cancer November 1-2, 2017 Toronto, Canada Theme: Explore New Discoveries in Breast Cancer: Health Promotion and Awareness Dear Prospective Sponsor/Exhibitor,
MEDICINES ACT 395/1987. Unofficial translation; Amendments up to 1340/2010 included
MEDICINES ACT 395/1987 Unofficial translation; Amendments up to 1340/2010 included Chapter 1 General provisions Objectives Section 1 (80/2003) The objective of this Act is to maintain and promote the safety
Public health priorities in National Health Policy, Population Policy & HPNSDP. Md Humayun Kabir. Senior Secretary
Public health priorities in National Health Policy, Population Policy & HPNSDP Md Humayun Kabir Senior Secretary Ministry of Health & Family Welfare Government of the People s Republic of Bangladesh NATIONAL
Essential Medicines: update on policies and standards
Essential Medicines: update on policies and standards Jane Robertson Technical Officer Health Technologies and Pharmaceuticals (HTP) WHO Regional Office for Europe Pharmaceutical sector is complex R&D
INDONESIA Culling Compensation Policy and Practice
INDONESIA Culling Compensation Policy and Practice National Committee for Avian Influenza Control and Pandemic Influenza Preparedness (Komnas FBPI) 13 February 2007 1 Chronology of AI in Indonesia Interpandemic
Introducing NCCN Academy for Excellence & Leadership in Oncology April Program Overview
Introducing NCCN Academy for Excellence & Leadership in Oncology April 2009 Program Overview In 2009, NCCN will launch the NCCN Academy for Excellence & Leadership in Oncology, a series of oncology certificate
Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
Evidence based assessment of the value of innovation: pricing solutions and prospects
Evidence based assessment of the value of innovation: pricing solutions and prospects Karl Claxton 7/11/2017 How much can we pay for innovation? Cost Price > P* 60,000 30,000 per QALY Cost-effectiveness
Updated Resource Requirements for Sustainable Financing of the HIV Response in Indonesia
POLICY Brief June 2018 Updated Resource Requirements for Sustainable Financing of the HIV Response in Indonesia Authors: Health Policy Plus and Sub-Directorate for HIV/AIDS and STI of the Ministry of Health,
SPONSORSHIP, ADVERTISING, & EXHIBIT INVITATION
2018 National Energy Utility & Affordability Conference June 26-28, 2018 - Phoenix, AZ SPONSORSHIP, ADVERTISING, & EXHIBIT INVITATION National Energy Utility & Affordability Conference June 26-28, 2018
ASEAN Activities on Increasing Access to ARV and HIV Related Supplies
ASEAN Activities on Increasing Access to ARV and HIV Related Supplies Consultation on Integrating Prevention and Management of STI/HIV/AIDS into Reproductive, Maternal and Newborn Health Services and the
Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016
Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016 To whom it may concern, Thank you for the opportunity to submit on the Draft Public Health (Tobacco) Regulations 2016
Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine
Research Paper Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine Abdel Naser Zaid a, Rowa Al-Ramahi b, Qusai Shahed c, Belal Saleh c and Josephean Elaraj b Departments